Innovation Policy and the EconomyAdam B. Jaffe, Josh Lerner, Scott Stern MIT Press, 2001 - 252 頁 This new annual series, sponsored by the National Bureau of Economic Research, will provide a forum for research on the interactions between public policy and the innovation process. Discussions will cover all types of policy that affect the ability of an economy to achieve scientific and technological progress or that affect the impact of science and technology on economic growth. |
內容
Publicly Funded Science and the Productivity of the Pharmaceutical Industry | 1 |
Creating Markets for New VaccinesPart I Rationale | 35 |
Creating Markets for New VaccinesPart II Design Issues | 73 |
Navigating the Patent Thicket Cross Licenses Patent Pools and Standard Setting | 119 |
Commercialization of the Internet The Interaction of Public Policy and Private Choices or Why Introducing the Market Worked So Well | 151 |
Numbers Quality and Entry How Has the BayhDole Act Affected US University Patenting and Licensing? | 187 |
Should the Government Subsidize Supply or Demand in the Market for Scientists and Engineers? | 221 |
其他版本 - 查看全部
常見字詞
activities analysis antitrust basic Bayh-Dole Act biomedical inventions cines commercial companies competition copayments cost cost-effective cross licenses DALYS saved developing countries diseases doses drugs Economic effects eligibility and pricing example federal graduate HIV vaccine immunized important increase industry innovation inputs institutions Intel intellectual property rights Intergraph Internet access ISPs malaria vaccine manufacturer ment million National National Science Board nomic nonacademic patents NSE degrees Orphan Drug paper patent pool patent thicket patenting and licensing Ph.D pharmaceutical firms potential vaccine developers private sector problem public sector publicly funded research pull programs purchase vaccines research and development revenue scientists and engineers sector research standard setting subsidies suggests tax credit technical tion tuberculosis U.S. universities UC and Stanford undergraduate university patenting users vaccine purchase commitment vaccine purchase program vaccine research World Bank World Health Organization
熱門章節
第 115 頁 - New Vaccine Development, Establishing Priorities, vol. 2: Diseases of Importance in Developing Countries. Washington, DC: National Academy Press, 1986. Johnston, Mark, and Richard Zeckhauser, "The Australian Pharmaceutical Subsidy Gambit: Transmitting Deadweight Loss and Oligopoly Rents to Consumer Surplus," National Bureau of Economic Research (Cambridge, MA) Working Paper 3783, July 1991.